Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 3
2006 4
2007 8
2008 5
2009 1
2010 3
2011 4
2012 14
2013 8
2014 7
2015 6
2016 8
2017 17
2018 8
2019 15
2020 10
2021 11
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
Pathophysiology of infective endocarditis.
Keynan Y, Rubinstein E. Keynan Y, et al. Curr Infect Dis Rep. 2013 Aug;15(4):342-6. doi: 10.1007/s11908-013-0346-0. Curr Infect Dis Rep. 2013. PMID: 23737237
Vancomycin-resistant enterococci.
Rubinstein E, Keynan Y. Rubinstein E, et al. Among authors: keynan y. Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006. Crit Care Clin. 2013. PMID: 24094380 Review.
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.
Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J, Costiniuk C, Daley P, Daneman N, Douglas J, Downey C, Duan E, Duceppe E, Durand M, English S, Farjou G, Fera E, Fontela P, Fowler R, Fralick M, Geagea A, Grant J, Harrison LB, Havey T, Hoang H, Kelly LE, Keynan Y, Khwaja K, Klein G, Klein M, Kolan C, Kronfli N, Lamontagne F, Lau R, Fralick M, Lee TC, Lee N, Lim R, Longo S, Lostun A, MacIntyre E, Malhamé I, Mangof K, McGuinty M, Mergler S, Munan MP, Murthy S, O'Neil C, Ovakim D, Papenburg J, Parhar K, Parvathy SN, Patel C, Perez-Patrigeon S, Pinto R, Rajakumaran S, Rishu A, Roba-Oshin M, Rushton M, Saleem M, Salvadori M, Scherr K, Schwartz K, Semret M, Silverman M, Singh A, Sligl W, Smith S, Somayaji R, Tan DHS, Tobin S, Todd M, Tran TV, Tremblay A, Tsang J, Turgeon A, Vakil E, Weatherald J, Yansouni C, Zarychanski R; Canadian Treatments for COVID-19 (CATCO); Association of Medical Microbiology and Infectious Disease Canada (AMMI) Clinical Research Network and the Canadian Critical Care Trials Group. Ali K, et al. Among authors: keynan y. CMAJ. 2022 Feb 22;194(7):E242-E251. doi: 10.1503/cmaj.211698. Epub 2022 Jan 19. CMAJ. 2022. PMID: 35045989 Free PMC article. Clinical Trial.
Quinolones for mycobacterial infections.
Rubinstein E, Keynan Y. Rubinstein E, et al. Among authors: keynan y. Int J Antimicrob Agents. 2013 Jul;42(1):1-4. doi: 10.1016/j.ijantimicag.2013.03.005. Epub 2013 May 1. Int J Antimicrob Agents. 2013. PMID: 23643393 Review.
Knowledge brokering on infectious diseases for public health.
Haworth-Brockman M, Keynan Y. Haworth-Brockman M, et al. Among authors: keynan y. Can Commun Dis Rep. 2021 Mar 31;47(3):160-164. doi: 10.14745/ccdr.v47i03a06. eCollection 2021 Mar 31. Can Commun Dis Rep. 2021. PMID: 34012340 Free PMC article.
Short-course therapy for severe infections.
Rubinstein E, Keynan Y. Rubinstein E, et al. Among authors: keynan y. Int J Antimicrob Agents. 2013 Jun;42 Suppl:S22-4. doi: 10.1016/j.ijantimicag.2013.04.013. Epub 2013 May 22. Int J Antimicrob Agents. 2013. PMID: 23706543 Review.
Strengthening tuberculosis surveillance in Canada.
Haworth-Brockman MJ, Keynan Y. Haworth-Brockman MJ, et al. Among authors: keynan y. CMAJ. 2019 Jul 2;191(26):E743-E744. doi: 10.1503/cmaj.72225. CMAJ. 2019. PMID: 31266792 Free PMC article. No abstract available.
Atypical bacterial pneumonia in the HIV-infected population.
Head BM, Trajtman A, Rueda ZV, Vélez L, Keynan Y. Head BM, et al. Among authors: keynan y. Pneumonia (Nathan). 2017 Aug 25;9:12. doi: 10.1186/s41479-017-0036-z. eCollection 2017. Pneumonia (Nathan). 2017. PMID: 28856082 Free PMC article. Review.
Legionella co-infection in HIV-associated pneumonia.
Head BM, Trajtman A, Bernard K, Burdz T, Vélez L, Herrera M, Rueda ZV, Keynan Y. Head BM, et al. Among authors: keynan y. Diagn Microbiol Infect Dis. 2019 Sep;95(1):71-76. doi: 10.1016/j.diagmicrobio.2019.03.005. Epub 2019 Mar 14. Diagn Microbiol Infect Dis. 2019. PMID: 31072645
127 results